IP Library Granted Patent US 9,498,448
Granted Patent B2
US 9,498,448 · App. 14/843,097 · Granted Nov 22, 2016

Pharmaceutical compositions comprising monoterpenes

Inventors: Thomas Chen (La Canada, CA); Daniel Levin (La Canada, CA); Satish Puppali (Rancho Cucamonga, CA)
Assignee: NeOne Technologies, Inc.
A61K31/045A61K31/4188A61K45/06A61N5/10C07C29/78C07C29/88C07C29/92C07C67/14C07C201/12C07C201/16C07B2200/07C07C2101/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,498,448
App. No.
14/843,097
Granted
Nov 22, 2016
Kind
B2
Abstract

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

Claims (15)

1. A process for purifying (S)-perillyl alcohol comprising the steps of:

(a) derivatizing a mixture comprising (S)-perillyl alcohol to form a perillyl alcohol derivative;

(b) crystallizing the perillyl alcohol derivative;

(c) separating the perillyl alcohol derivative;

(d) releasing the (S)-perillyl alcohol from the separated perillyl alcohol derivative from step (c) by hydrolysis; and,

(e) isolating the (S)-perillyl alcohol from step (d),

wherein the isolated (S)-perillyl alcohol has a purity of greater than about 98.5% (w/w).

2. The process of claim 1 , wherein the perillyl alcohol derivative is a perillyl alcohol ester.

3. The process of claim 2 , wherein the ester is benzoate ester.

4. The process of claim 3 , wherein the benzoate ester I 3,5-dinitrobenzoate ester.

5. The process of claim 1 , wherein the isolated (S)-perillyl alcohol has a purity of greater than about 99.0% (w/w).

6. The process of claim 5 , wherein the isolated (S)-perillyl alcohol has a purity of greater than about 99.5% (w/w).

7. The process of claim 1 , wherein the mixture further comprises natural-product-derived or other impurities.

8. The process according to claim 1 , wherein the hydrolysis is accomplished in the presence of NaOH, an alcoholic solvent and water.

9. The process according to claim 8 wherein the alcoholic solvent is methanol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2023
From: NEONC TECHNOLOGIES INC.
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 063726/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2015
From: CHEN, THOMAS; LEVIN, DANIEL; PUPPALI, SATISH
To: NEONC TECHNOLOGIES INC.
Reel/Frame 036883/0486 →
Continuity (4)
Continuation 13939834 · Jul 11, 2013
Continuation 13040059 · Mar 3, 2011
Provisional Application 61310231 · Mar 3, 2010
Related Publication 20160039730A1 · Feb 11, 2016